| Pharmaceutical active ingredients: |
| Estradiol ValerateNorethindrone Enanthate |
| Available forms, composition and doses of Mesigyna Instayect: |
| Injectable; Injection; Estradiol Valerate 5 mg; Norethindrone Enanthate 50 mg / ml |
| Mesigyna Instayect medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA53 - Estradiol, combinationsG03FA01 - Norethisterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mericomb | Estradiol Valerate; Norethindrone | Novartis; Pierre Fabre |
| Mericomb Mite | Estradiol Valerate; Norethindrone | Novartis |
| Merigest | Estradiol Valerate; Norethindrone | Novartis; Pierre Fabre |
| Merigest Sequi | Estradiol Valerate; Norethindrone | Novartis |
| Mesigyna | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Mesygina | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Norigynon | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Cyclacur | Estradiol Valerate; Norgestrel | Bayer Schering Pharma |
| Postoval | Estradiol Valerate; Norgestrel | Wyeth |
| Progyluton | Estradiol Valerate; Norgestrel | Bayer Schering Pharma; Perrigo; Zuellig Pharma |